Please use this identifier to cite or link to this item:
|Title:||Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia|
|Citation:||Lee, P.P.W., Chen, T.-X., Jiang, L.-P., Chan, K.-W., Yang, W., Lee, B.-W., Chiang, W.-C., Chen, X.-Y., Fok, S.F.S., Lee, T.-L., Ho, M.H.K., Yang, X.-Q., Lau, Y.-L. (2010-01). Clinical characteristics and genotype-phenotype correlation in 62 patients with X-linked agammaglobulinemia. Journal of Clinical Immunology 30 (1) : 121-131. ScholarBank@NUS Repository. https://doi.org/10.1007/s10875-009-9341-5|
|Abstract:||Introduction: X-linked agammagobulinemia (XLA) is a primary immunodeficiency disorder caused by Bruton's tyrosine kinase (Btk) gene mutation. Recent studies suggested genotype-phenotype correlation in XLA, but a definitive association remains controversial. Patients and Methods: We examined the relationship between specific Btk gene mutations and severity of clinical presentation in 62 patients with XLA. Disease severity was assessed by the age of disease onset and the presence of severe infections, while mutations were classified into severe and mild based on structural and functional consequence by bioinformatics analysis. Results: Fifty-six Btk mutations were identified in 62 patients from 57 kindreds. Variation in phenotypes was observed, and there was a tendency of association between genotype and age of disease onset as well as occurrence of severe infections. Conclusion: A critical analysis of the circumstances upon presentation also revealed that under-recognition of recurrent infections and relevant family history are important hurdles to timely diagnosis of XLA. © 2009 Springer Science+Business Media, LLC.|
|Source Title:||Journal of Clinical Immunology|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Mar 23, 2019
WEB OF SCIENCETM
checked on Mar 13, 2019
checked on Feb 8, 2019
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.